Client News

MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis

Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic

CorTec’s Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind

DINAMIQS receives Swissmedic license for viral vector manufacturing and testing

mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics

Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics

InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

AFYREN receives €3 million grant from the Grand Est Region through the European Just Transition Fund

CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)

Formycon reports successful financial year 2025 with important operational progress, growing market presence and strategic partnerships